» Articles » PMID: 27981256

Adverse Perinatal Outcomes in Borderline Amniotic Fluid Index

Overview
Date 2016 Dec 17
PMID 27981256
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Normal amniotic fluid predicts normal placental function, fetal growth and fetal well-being.

Objective: To determine adverse pregnancy outcomes in borderline amniotic fluid index (AFI).

Materials And Methods: Pregnant women (37-40 wks) with diagnosis of borderline AFI between December 2012 and August 2014 were identified. Antepartum, intrapartum and neonatal data were collected and compared with those of pregnant women with normal AFI. An AFI less than 8 and more than 5 cm was defined for borderline AFI. Pregnancy outcomes included Cesarean section for non-reassuring fetal heart rate, meconium stained amniotic fluid, 5-min Apgar score <7, low birth weight, umbilical cord blood pH at term and NICU admission.

Results: Gestational age at delivery in pregnancies with borderline AFI was significantly lower than normal AFI. Cesarean section rate for non-reassuring fetal heart rate in women of borderline AFI was significantly higher and there was an increased incidence of birth weight less than 10 percentile for gestation age in borderline AFI group. Incidence of low Apgar score and low umbilical artery pH in pregnancies with borderline AFI was significantly higher than women with normal AFI. There were no significant difference in the rate of NICU admission and meconium staining in both groups.

Conclusion: There are significant differences for adverse pregnancy outcomes , such as Cesarean section due to non-reassuring fetal heart rate, birth weight less than 10 percentile for gestation age, low 5 min Apgar score and low umbilical artery pH between pregnancies with borderline and normal AFI.

Citing Articles

Perinatal Outcomes of Pregnancies with Borderline Oligohydramnios at Term.

Sgayer I, Elafawi M, Braude O, Abramov S, Lowenstein L, Odeh M Fetal Diagn Ther. 2024; 52(1):59-64.

PMID: 39173605 PMC: 11793092. DOI: 10.1159/000541008.


The Effect of Sildenafil on Pregnancy Outcomes in Pregnant Women With Idiopathic Borderline Oligohydramnios: A Randomized Controlled Trial.

Dastjerdi M, Ghahghaei-Nezamabadi A, Tehranian A, Mesgaran M J Family Reprod Health. 2022; 16(2):124-131.

PMID: 36457659 PMC: 9678853. DOI: 10.18502/jfrh.v16i2.9482.


Comparison of Perinatal and Maternal Outcomes in Borderline Versus Normal Amniotic Fluid Index in a Tertiary Care Center in Odisha: An Observational Prospective Study.

Vyas A, Prasanna G, Dash S, Rath S Cureus. 2021; 13(11):e19876.

PMID: 34963870 PMC: 8709811. DOI: 10.7759/cureus.19876.


Comparison of the effectiveness and pregnancy outcomes of labor induction with dinoprostone or single-balloon catheter in term nulliparous women with borderline oligohydramnios.

Zhang Y, Chen L, Yan G, Zhou M, Chen Z, Liang Z Chin Med J (Engl). 2021; 135(6):681-690.

PMID: 34935691 PMC: 9276138. DOI: 10.1097/CM9.0000000000001881.


Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.

Smith G, Moraitis A, Wastlund D, Thornton J, Papageorghiou A, Sanders J Health Technol Assess. 2021; 25(15):1-190.

PMID: 33656977 PMC: 7958245. DOI: 10.3310/hta25150.

References
1.
Kwon J, Kwon H, Kim Y, Park Y . Abnormal Doppler velocimetry is related to adverse perinatal outcome for borderline amniotic fluid index during third trimester. J Obstet Gynaecol Res. 2006; 32(6):545-9. DOI: 10.1111/j.1447-0756.2006.00459.x. View

2.
Kreiser D, El-Sayed Y, Sorem K, Chitkara U, Holbrook Jr R, Druzin M . Decreased amniotic fluid index in low-risk pregnancy. J Reprod Med. 2001; 46(8):743-6. View

3.
Banks E, Miller D . Perinatal risks associated with borderline amniotic fluid index. Am J Obstet Gynecol. 1999; 180(6 Pt 1):1461-3. DOI: 10.1016/s0002-9378(99)70037-2. View

4.
Modena A, Fieni S . Amniotic fluid dynamics. Acta Biomed. 2004; 75 Suppl 1:11-3. View

5.
Phelan J, Smith C, Broussard P, Small M . Amniotic fluid volume assessment with the four-quadrant technique at 36-42 weeks' gestation. J Reprod Med. 1987; 32(7):540-2. View